McDonnell Thomas P 4
4 · Neos Therapeutics, Inc. · Filed Mar 5, 2018
Insider Transaction Report
Form 4
McDonnell Thomas P
Chief Commercial Officer
Transactions
- Award
Common Stock
2018-03-01+18,750→ 36,750 total - Award
Stock Option (Right to Buy)
2018-03-01+56,250→ 56,250 totalExercise: $8.30Exp: 2028-03-01→ Common Stock (56,250 underlying)
Footnotes (2)
- [F1]Represents shares of common stock underlying restricted stock unit grants awarded to the Reporting Person. The restricted stock units will vest in four equal, annual installments beginning on March 1, 2019.
- [F2]This stock option will vest in four equal, annual installments beginning on March 1, 2019.